Clinical significance of hyperbilirubinemia in the CASTLE study

Purpose of the study: While unconjugated hyperbilirubinemia is associated with the use of ritonavir-boosted atazanavir (ATV/r), the nature of the hyperbilirubinemia over time and its clinical significance has not been well-characterized in controlled studies. The purpose of this study is to describe the patterns and clinical significance of hyperbilirubinemia in patients treated with ATV/r in the CASTLE study. Supplement: Abstracts of the Tenth International Congress on Drug Therapy in HIV Infection http://www.biomedcentral.com/content/pdf/1758-2652-13-S4-info.pdf Conference: Tenth International Congress on Drug Therapy in HIV Infection 7-11 November 2010 Glasgow, UK (Published: 8 November 2010) doi:10.1186/1758-2652-13-S4-P93 Cite this article as: Uy et al.: Clinical significance of hyperbilirubinemia in the CASTLE study. Journal of the International AIDS Society 2010 13 (Suppl 4):P93. Full text: PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113101/